Recombinant histones as an instrument for delivery of nucleic acids into eukaryotic cells

Zinovyeva M.V.; Sass A.V.; Vvedensky A.V.; Potapov V.K.; Nikolaev L.G.; Sverdlov E.D.

doi:https://doi.org/10.17116/molgen20183603130

Zinovyeva M.V.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Sass A.V.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Vvedensky A.V.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Potapov V.K.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Nikolaev L.G.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Sverdlov E.D.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia;
Institute of Molecular Genetics RAS, Kurchatov sq. 2, Moscow 123182, Russia

Recombinant histones as an instrument for delivery of nucleic acids into eukaryotic cells

Authors:

Zinovyeva M.V., Sass A.V., Vvedensky A.V., Potapov V.K., Nikolaev L.G., Sverdlov E.D.

More about the authors

Journal: Molecular Genetics, Microbiology and Virology. 2018;36(3): 30‑37

DOI: 10.17116/molgen20183603130

Read: 1986 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zinovyeva MV, Sass AV, Vvedensky AV, et al. . Recombinant histones as an instrument for delivery of nucleic acids into eukaryotic cells. Molecular Genetics, Microbiology and Virology. 2018;36(3):30‑37. (In Russ.)
https://doi.org/10.17116/molgen20183603130

Подписка 2026 Молекулярная генетика, микробиология и вирусология (Molecular Genetics, Microbiology and Virology)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Naturally occurring positively charged proteins can be promising carriers for nucleic acids transport in gene therapy. The most attractive alternative among them are histones. In this work we describe expression and purification of recombinant human histones H2A and H2B and of chimeric protein of histone H2A and HIV-1 TAT fragment (TAT-peptide). The proposed purification method allows for significant decrease of bacterial endotoxins content in the final histone preparation which makes possible to use these proteins in the in vivo experiments. The transfection ability of plasmid DNA complexes with core histones H2A and H2B and the chimeric histone was demonstrated. With the use of histones H2A and H2B a highly specific transfection of human HT1080 cell line was detected, whereas transfection with complexes of DNA with chimeric H2A-TAT protein was observed for many cell lines.

Keywords:

non-viral delivery of nucleic acids into cell

recombinant histones purification

TAT-peptide

endotoxin

Authors:

Zinovyeva M.V.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Sass A.V.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Vvedensky A.V.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Potapov V.K.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Nikolaev L.G.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia

Sverdlov E.D.

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Mikluho-Maklaya 16/10, Moscow 117997, Russia;
Institute of Molecular Genetics RAS, Kurchatov sq. 2, Moscow 123182, Russia

Close metadata

References:

Bakhtiar A, Sayyad M, Rosli R, Maruyama A, Chowdhury EH. Intracellular delivery of potential therapeutic genes: prospects in cancer gene therapy. Curr Gene Ther. 2014;14:247-257.
Nayerossadat N, Maedeh T, Ali PA. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res. 2012;1:27.
Berry GE, Asokan A. Cellular transduction mechanisms of adeno-associated viral vectors. Curr Opin Virol. 2016;21:54-60.
Ibraheem D, Elaissari A, Fessi H. Gene therapy and DNA delivery systems. Int J Pharm. 2014;459:70-83.
Lukashev AN, Zamyatnin AAJr. Viral Vectors for Gene Therapy: Current State and Clinical Perspectives. Biochemistry (Mosc). 2018;81:700-708.
Ramamoorth M, Narvekar A. Non viral vectors in gene therapy- an overview. J Clin Diagn Res. 2015;9:GE01-6.
Slivac I, Guay D, Mangion M, Champeil J, Gaillet B. Non-viral nucleic acid delivery methods. Expert Opin Biol Ther. 2017;17:105-118.
Zhang C, Jin R, Zhao P, Lin C. A family of cationic polyamides for in vitro and in vivo gene transfection. Acta Biomater. 2015;22:120-130.
Zhang P, Wagner E. History of Polymeric Gene Delivery Systems. Top Curr Chem (Cham). 2017;375:26.
Stanzl EG, Trantow BM, Vargas JR, Wender PA. Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. Acc Chem Res. 2013;46:2944-2954.
Kouchakzadeh H, Abbas Shojaosadati S. The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment. Curr Pharm Des. 2016;22:3455-3465.
Komin A, Russell LM, Hristova KA, Searson PC. Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges. Adv Drug Deliv Rev. 2017;110-111:52-64.
Radis-Baptista G, Campelo IS, Morlighem JRL, et al. Cell-penetrating peptides (CPPs): From delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis. J Biotechnol. 2017;252:15-26.
Balicki D, Beutler E. Histone H2A significantly enhances in vitro DNA transfection. Mol Med. 1997;3:782-787.
Puebla I, Esseghir S, Mortlock A, et al. A recombinant H1 histone-based system for efficient delivery of nucleic acids. J Biotechnol. 2003;105:215-226.
Kaouass M, Beaulieu R, Balicki D. Histonefection: Novel and potent non-viral gene delivery. J Control Release. 2006;113:245-254.
Reilly MJ, Larsen JD, Sullivan MO. Histone H3 tail peptides and poly(ethylenimine) have synergistic effects for gene delivery. Mol Pharm. 2012;9:1031-1040.
Hariton-Gazal E, Rosenbluh J, Graessmann A, et al. Direct translocation of histone molecules across cell membranes. J Cell Sci. 2003;116:4577-4586.
Wagstaff KM, Glover DJ, Tremethick DJ, Jans DA. Histone-mediated transduction as an efficient means for gene delivery. Mol Ther. 2007;15:721-731.
Schneeweiss A, Buyens K, Giese M, et al. Synergistic effects between natural histone mixtures and polyethylenimine in non-viral gene delivery in vitro. Int J Pharm. 2010;400:86-95.
Torchilin VP. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev. 2008;60:548-558.
Sawant R, Torchilin V. Intracellular transduction using cell-penetrating peptides. Mol Biosyst. 2011;6:628-640.
Ulasov AV, Khramtsov YV, Trusov GA, et al. Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy. Mol Ther. 2011;19:103-112.
Johns EW. The isolation and purification of histones. Methods Cell Biol. 1977;16:183-203.
von Holt C, Brandt WF, Greyling HJ, et al. Isolation and characterization of histones. Methods Enzymol. 1989;170:431-523.
Tanaka Y, Tawaramoto-Sasanuma M, Kawaguchi S, et al. Expression and purification of recombinant human histones. Methods. 2004;33:3-11.
Shechter D, Dormann HL, Allis CD, Hake SB. Extraction, purification and analysis of histones. Nat Protoc. 2007;2:1445-1457.
Gusarov DA. Methods of bacterial endotoxines removal from protein solutions. Biopharmaceutical J. 2009;1(3):10-17. (In Russ.)
Gusarov D, Sokolova I, Vorobjeva T, Brykova N. Positively charged proteins: separation and depyrogenation by means of HPLC (by the example of recombinant histone H1.3 variant). Biopharmaceutical J. 2011;3:16-23. (In Russ.)
Klinker H, Haas C, Harrer N, Becker PB, Mueller-Planitz F. Rapid purification of recombinant histones. PLoS One. 2014;9:e104029.
Fujitani H, Holoubek V. Recovery of histones by acid extraction from chromatin and from artificial DNA-histone complex. Tex Rep Biol Med. 1974;32:461-478.
Kawashige M, Sendo T, Otsubo K, et al. Quality evaluation of commercial lyophilized human growth hormone preparations. Biol Pharm Bull. 1995;18:1793-1796.
Ahangari G, Ostadali MR, Rabani A, et al. Growth hormone antibodies formation in patients treated with recombinant human growth hormone. Int J Immunopathol Pharmacol. 2004;17:33-38.
Balicki D, Reisfeld RA, Pertl U, et al. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma. Proc Natl Acad Sci USA. 2000;97:11500-11504.
Torchilin VP. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers. 2008;90:604-10.